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Dense fibrosis, which is caused by desmoplastic reac-
tion, is usually found in invasive ductal carcinoma and
may represent the alteration of the tumor microenvi-
ronment preceding tumor invasion. Thus, the dense
fibrotic zone around invasive ductal carcinoma can be
considered to be the actual tissue site of tumor micro-
environment, where the precedent alterations for tu-
mor invasion occur. To characterize the dense fibrotic
zone, we classified invasive ductal carcinoma tissue into
a tumor zone, a normal zone, and the novel interface
zone (IZ), which shows dense fibrosis. The postulated IZ
is a 5-mm-wide belt that circles the tumor margin and
overlaps with normal tissue. Of the extracellular matrix
components, laminin-332 was specifically overex-
pressed in the IZ. Events that appear to be similar to the
epithelial-mesenchymal transition, a novel source of
myofibroblast formation from epithelial cells, were ob-
served in the IZ, according to the following characteris-
tics: overexpression of matrix metalloproteinase 3,
membrane type 1matrix metalloproteinase, snail, and
zinc finger E-box-binding homeobox 1, and the gain of
N-cadherin expression, as well as the down-regulation
of miR200c. The myofibroblasts isolated from the IZ,
which were designated interface zone-fibroblast, dis-
played laminin-332 and membrane type 1matrix met-
alloproteinase overexpression, in contrast with both
cancer-associated fibroblasts and normal breast fibro-
blasts. Taken together, our results suggest that the IZ,
which shows dense fibrosis, may provide a specialized
microenvironment for guiding tumor invasion: the fi-
brosis caused by laminin-332 overexpressing myofibro-
blast formation (interface zone-fibroblast) via epithelial-
mesenchymal transition. (Am J Pathol 2011, 178:373–381;
DOI: 10.1016/j.ajpath.2010.11.028)The tumor microenvironment (TME) is important for tu-
morigenesis and tumor progression.1,2 For breast cancer
surgery and treatment, it is necessary to define the TME
of a tissue, which is important in tumor progression. Nev-
ertheless, no attempt has been made to define the TME of
an actual tissue area. The dense fibrosis around the
tumor burden, which is caused by desmoplastic reaction
of the invading tumor, can be thought of as the alteration
of TME for tumor invasion. Invasive ductal carcinoma
(IDC), which is a representative type of invasive breast
cancer, may be an ideal model for studying TME alter-
ations during tumor invasion because of the accompany-
ing desmoplasia. In our study, the dense fibrotic zone of
IDC was first designated as “the interface zone” (IZ) and
was then characterized. The initial concept of the IZ orig-
inated from a traditionally and widely used surgical mar-
gin showing low recurrence: a 5-mm-wide tissue zone
surrounding the tumor burden and adjoining the normal
tissue.3
Fibrosis is the formation of excess fibrous connective
tissues caused by physiological stress, such as injury
and inflammation. When a tumor becomes invasive or
metastatic, dense fibrosis is detected around the tumor
burden, especially in solid tumor tissue.4 In addition,
basement membrane stiffening, one of the representative
TME alterations for tumor progression, is caused by fi-
brosis.5 The transition of epithelia to myofibroblast via
epithelial-mesenchymal transition (EMT), which can be
induced by matrix metalloproteinase 3 (MMP3), has been
reported to be a novel source of myofibroblast forma-
tion.6,7 Membrane type 1 (MT1)-MMP expression pro-
duces some of the same effects as MMP3: fibrosis in
mammary glands8 and EMT in prostate cancer.9 Thus,
the fibrotic zone in IDC could be formed by myofibro-
blasts that are transdifferentiated from nontumoral epithe-
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sion.10
Laminin-332, an extracellular matrix (ECM) component
composed of LAMA3, LAMB3, and LAMC2 chains, is
expressed by both tumor and stromal cells. Laminin-332
expression is increased in several types of tumors.11–13
However, some cancers, such as advanced breast and
prostate cancer, reveal decreased expression of laminin-
332.14,15 Similar to other laminins, laminin-332 primarily
serves an adhesive function in mature normal tissue, but
has a more complex role in tumor cell survival, inva-
sion, and migration.12 During tumor progression, lami-
nin-332 binds to integrin 64, specifically the 4 sub-
unit, and signals through the PI3K and RAC1 pathways
to promote the survival, invasion, and directional mi-
gration of tumor cells.16,17 Moreover, transforming growth
factor- (TGF-) completes the EMT process in the pres-
ence of laminin-332.18
To understand the alterations of TME in IDC tissue
during tumor invasion, we first introduced the novel con-
cept of IZ in our study and focused on its external feature,
dense fibrosis. Based on our results, the IZ may be con-
sidered the actual tissue site of TME, where tumor pro-
gression-inducing events actively occur. Therefore, the
IZ may be a potent target for cancer treatment, such as
neoadjuvant therapy, and should be further studied.
Materials and Methods
Tissue Acquisition
Breast cancer tissues were acquired from 11 patients (4
ductal carcinoma in situ (DCIS) and 7 IDC not otherwise
specified) by macroscopic dissection with needle shred-
ding, according to the spatial serial mapping: (1) real tumor
burden, termed the tumor zone (TZ), around the epicenter
of the main tumor; (2) directly adjacent normal-like tissue up
to 5 mm from the peripheral margin of the tumor, termed the
IZ; and (3) remote normal tissue located at least 10mm from
Table 1. Primer Sequence and Temperature for PCR
Primer Direction
LAMA3 Forward 5-GCTCAGCTGTT
Reverse 5-TGTCTGCATCT
LAMC2 Forward 5-GATGGCATTCA
Reverse 5-TCGAGCACTAA
ITGA6 Forward 5-GACTTGAAAGA
Reverse 5-TAGCACCTGTT
ITGB4 Forward 5-CCTGTACCCGT
Reverse 5-AGGCCATAGCA
Snail Forward 5-GAGGCGGTGGC
Reverse 5-GACACATCGGT
Twist Forward 5-CGGGAGTCCGC
Reverse 5-TGAATCTTGCT
ZEB1 Forward 5-TGCACTGAGTG
Reverse 5-TGGTGATGCTG
GAPDH Forward 5-ACAACTTTGGT
Reverse 5-AAATTCGTTGT
URT Forward 5-AACGAGACGAC
Universal PCR Forward 5-AACGAGACGAC
miR200c Forward 5-ATACTGCCGGGURT, universal reverse transcription.the tumor margin, termed the normal zone (NZ). For the
conceptual construction, small IDCs less than 10 mm2 in
gross dimension were selected as a prototype with repro-
ducible spatial identification. Larger tumors more than 10
mm2 in dimension with a vague infiltrative boundary or
cases other than ductal carcinomas were excluded for fu-
ture evaluation. For validation of microscopic findings, other
samples from corresponding areas were fixed in 10% neu-
tral buffered formalin, embedded in paraffin, sectioned into
4-m sections, and examined by H&E staining.
ECM Array for Screening Interface-Specific
Factors
Total RNAwas extracted using a Protect Mini Kit (Invitrogen,
Carlsbad, CA). After verifying the size and integrity of the
RNA using Experion (Bio-Rad, Hercules, CA), total RNA
was reverse transcribed using an RT2 First Strand Kit (SA-
Biosciences, Frederick, MD). The human ECM and Adhe-
sion Molecules RT2 Profiler PCR Array and RT2 Real-Time
SYBR Green/Fluorescein PCR master Mix (SABiosciences)
were used to analyze ECM gene transcripts. The PCR array
was processed on an IQ5 iCycler (Bio-Rad), as described
by the manufacturer, and the data were analyzed using the
program provided on the manufacturer’s website (http://
www.sabiosciences.com/pcr/arrayanalysis.php). For data
analysis, P  0.05 values were considered statistically sig-
nificant.
Quantitative Analysis of Gene Transcript
Expression Using Real-Time PCR
Total RNA was transcribed using Superscript III (Invitro-
gen), and 25 ng of the resulting cDNA and 20 pM primers
were added to a PCR mixture prepared with the QuantiTect
SYBR green PCR kit (Qiagen, Valencia, CA). Primer se-
quences and annealing temperature are shown in Table 1.
PCR reactions were performed in triplicate using the follow-
ing cycling conditions: 10 minutes at 95°C, 35 cycles of 40
nce Annealing temperature (°C)
TTGA-3 55
TAGC-3
AGAAG-3 56
CCTTTGG-3
TGAATGC-3 53
TTGC-3
GACT-3 53
CGTA-3
AG-3 52
CAG-3
TA-3 52
TGTC-3
AAGC-3 55
GACG-3
GGAA-3 55
CAGG-3
ACTTTTTTTTTTTTT-3 42
ACTTT-3 53
ATGG-3 53Seque
TGTGG
GCCAA
CTGCG
GAGAA
AATGG
TGCTG
ATTGC
GACCT
AGACT
CAGAC
AGTCT
CAGCT
TGGAA
AAAGA
ATCGT
CATAC
GACAG
GACAG
TAATG
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temperature, and 1 minute at 72°C, followed by 10 minutes
at 72°C. The expression of gene transcripts was normalized
to endogenous glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) expression, and calculated according to the
Ct method using Opticon Monitor 3 (ver. 3.1; Bio-Rad,
Hercules, CA). Values of P  0.05 were considered statis-
tically significant.
Differential Expression of Tumor Progression-
Related Proteins
Tissues were lysed in 500 l Protein Extraction Solution
(Intron Biotech, Seongnan-si, Korea), homogenized with a
30-gauge needle, incubated for 30minutes at 4°C, and then
purified by centrifugation at 13,000 rpm. After quantifying
proteins in extracts using the Bradford method, 20-g pro-
tein was electrophoresed on 10% Tris/glycine gels (Invitro-
gen), transferred to polyvinylidene diflouride membranes
(Millipore, Billerica, MA), and probed with primary antibod-
ies against laminin 3, laminin 2, integrin 6, integrin 4,
SNAIL, TWIST, zinc finger E-box-binding homeobox 1
(ZEB1), N-cadherin, MMP3, MT1-MMP, and GAPDH (Santa
Cruz Biotechnology, Santa Cruz, CA). Primary antibodies
were detected by horseradish peroxidase-conjugated sec-
ondary antibodies (Invitrogen), and visualized using en-
hanced chemiluminescence reagents (Santa Cruz Biotech-
nology). Relative signal intensities were analyzed using
TINA software (ver. 2.0; Raytest, Straubenhart, Germany); P
values 0.05 were considered statistically significant for all
data.MiR200c Expression as an EMT Phenotype
For amplification of microRNA, mature microRNA was
first modified by the addition of a poly(A) tail, as de-
scribed previously.19 Briefly, 1 g total RNA in 15 l
DNase/RNase-free water was added to a mixture con-
taining 2 l 10 X E-PAP buffer and 1 l 10 mmol/L ATP.
One microliter Escherichia coli Poly(A) polymerase I
(E-PAP; New England Biolabs, Ipswich, MA) was then
added; the reaction mixture was incubated for 1 hour at
37°C. Poly(A)-tail-added microRNAs were transcribed
using Superscript III (Invitrogen), and 25 ng of the result-
ing cDNA and 20 pM primers were added to a PCR
mixture prepared with the QuantiTect SYBR green PCR
kit (Qiagen). Primer sequences and annealing tempera-
tures are shown in Table 1. PCR reactions were per-
formed in triplicate using the following cycling conditions:
10 minutes at 95°C, 35 cycles of 40 seconds at 94°C, 1
minute at 53°C, and 1 minute at 72°C, followed by 10
minutes at 72°C. The expression of gene transcripts was
normalized to endogenous GAPDH expression, and cal-
culated according to the Ct method using Opticon
Monitor 3 (ver. 3.1). Values of P  0.05 were considered
statistically significant.
Isolation of Primary Fibroblasts
Each spatial fraction from fresh tissues was used to
isolate primary fibroblasts. Fresh tissues obtained from
each different zone under sterile conditions were
minced into smaller pieces, placed in a digestion so-
Figure 1. Distinct gene expression in the inter-
face zone of invasive ductal carcinoma. A: Breast
cancer tissues were acquired by macroscopic
dissection based on geographical mapping as
follows: (1) tumor burden at the epicenter of the
tumor zone (TZ); (2) a 5-mm-wide interface tis-
sue (IZ) located between the periphery of the
tumor tissue and the adjacent normal tissue; and
(3) normal zone (NZ) located at least 10 mm
away from the tumor margin. Tissue sections
(0.4-m thick) were stained with H&E. B: Fold-
differences in the expression of basement mem-
brane and cell-matrix adhesion-related constitu-
ents of the ECM in the IZ of IDC relative to the
TZ and/or NZ were determined using an ECM
gene transcript array. LAMA3 transcripts were
upregulated 2-fold in the IZ compared with
the TZ and NZ. LAMC2, ITGA6, and ITGB4 tran-
scripts were also highly expressed in the IZ com-
pared to the TZ. C: Quantitative analysis of
LAMA3, LAMC2, ITGA6, and ITGB4 using real-
time PCR. LAMA3, LAMC2, ITGA6, and ITGB4
were all significantly upregulated in the IZ of
IDC. D: Clustergram based on ECM transcript
expression. ECM gene expression pattern of IZ
was closer to that of the TZ than the NZ in IDC.
Asterisk denotes more than twofold increased
expression and the values of P  0.05 in the IZ.
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Korea) and incubated at 37°C in a humidified 5% CO2
incubator overnight. Digested tissue was filtered
through a 70-m cell strainer. The cells were sus-
pended in medium: Ficoll (3:2) and separated by dif-
ferential centrifugation at 90  g for 2 minutes. The
supernatant containing fibroblasts was centrifuged at
485  g for 8 minutes, resuspended in Dulbecco’s
modified Eagle’s medium (DMEM)/F12 supplemented
with 10% fetal bovine serum and 100 IU/ml penicillin-
100 g/ml streptomycin (Gibco BRL, Grand island,
NY), and cultured at 37°C in a humidified 5% CO2
environment. The fibroblastic nature of the isolated
cells was confirmed by microscopic determination of
morphology portrait and immunofluorescence charac-
terization using an antibody against vimentin and
-smooth muscle actin (Abcam, Cambridge, UK).Direct Co-Culture Experiments
Primary fibroblasts were directly co-cultured with human
less-invasive MCF7 and highly invasive MDA-MB-231
(Korean Cell Line Bank, Seoul, Korea) breast carcinoma
cells, as described previously.20 Briefly, adherent fibro-
blasts or breast cancer cells were stained by incubation
for 45 minutes at 37°C in serum-free DMEM/F12 contain-
ing 5 mol/L CellTracker Green 5-chloromethylfluores-
cein diacetate (CMFDA; Invitrogen), a green fluorescent
dye. Subsequently, the dye solution was replaced with
fresh, prewarmed medium, and the cells were incubated
for an additional 2 hours at 37°C. The cells were then
washed twice with PBS, and unstained cancer cells or
fibroblasts were seeded onto plates containing CMFDA-
stained fibroblasts or cancer cells, respectively. Finally,
the co-cultures were incubated with minimum serum me-
Figure 2. Overexpression of tumor progres-
sion-related factors in the interface zone. A:
Zonal expression of laminin-2 and integrin 4.
In the IZ of IDC, especially from 3 to 4 mm,
laminin-2 and integrin 4 were significantly in-
creased. B: Specific overexpression of laminin-
332 and integrin 64 in the IZ of IDC. Both
laminin-332 and integrin 64 were significantly
increased in the IZ of IDC compared to the TZ
and NZ. There was no significant difference be-
tween zones of DCIS. Asterisk denotes more
than twofold increased expression, and P 0.05
in the IZ. C: Laminin-2 expression in IDC tis-
sue. Laminin-2 showed a strong immunoreac-
tivity to ECM belonging to the IZ to compare to
those of the TZ and NZ. At higher magnification,
laminin-2 expression was restricted to the peri-
lobular or ductal matrix in the IZ and also
weakly positive in the NZ.D: Integrin 4 expres-
sion in DCIS and IDC tissue. DCIS showed focal
accentuation of integrin 4 along the invading
fronts of the tumor nest (arrow). IDC displayed
diffusely strong membranous staining for inte-
grin 4 with a tendency of accentuation in the
periphery of the nest.
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icillin-100 g/ml streptomycin for 1 week. CMFDA-
stained cells were easily distinguished from unstained
cells by fluorescent microscopy and flow cytometry, al-
lowing separate measurements of each cell type to be
made independently.
Results
Distinct Gene Expression in the IZ of IDC
The IZ was defined as a 5-mm-wide belt zone surrounding
the TZ and adjoining the NZ (Figure 1A). The samples were
predominantly IDCs less than 10 mm2 in dimension. The TZ
was obtained from the epicenter of the tumor burden with-
out necrosis or hemorrhage. The IZ was predominantly
characterized by dense fibrosis with a few scattered lobu-
loductal units and without evidence of a tumor. The NZ was
entirely fibrofatty tissue at least 10 mm away from the tumor
margin with a few scattered normal lobuloductal units and a
scant amount of fibrosis or no apparent preneoplastic lob-
ules. The counterparts of DCIS were obtained from the same
histological location as those of IDC to serve as controls.
To determine whether the IZ of IDC shows distinct gene
alterations compared to the TZ and NZ, ECM genes, major
components of the TME, were analyzed using an mRNA
array. LAMA3, LAMC2 (basement membrane constituents),
ITGA6, and ITGB4 (cell-matrix adhesion-related molecules)
were specifically upregulated in the IZ of IDC (Figure 1B).
The expression of these genes was confirmed using real-time
PCR (Figure 1C). In addition, the degree of similarity amongthe TZ, IZ, and NZ was analyzed by drawing a clustergram,
and the IZ was relatively close to the TZ (Figure 1D).
Overexpression of Tumor Progression-Related
Factors, Laminin-332 and Integrin 64, in the IZ
To determine whether the 5-mm-wide IZ displays de-
tectable zone-specific alterations, we compared lami-
nin-2 and integrin 4 expression, which were identi-
fied in Figure 1, in serially dissected IZs at 1-mm
intervals. The expression of laminin-2 and integrin 4
increased particularly from 3 to 4 mm in the IZ of IDC,
but not in the counterparts of DCIS (Figure 2A). To
confirm that the distinct expression of laminin-332 and
integrin 64 in the IZ of IDC is reproducible, we
compared their expression in other samples of breast
cancer tissue. Western blot analyses showed the same
pattern of expression as the mRNA array: laminin-3,
laminin-2, integrin 6, and integrin 4 were overex-
pressed in the IZ of IDC, but not in the counterparts of
DCIS (Figure 2B).
The spatial expression of laminin-2 in the IZ was rel-
atively strong compared to those of the TZ and NZ in IDC
tissue. In the IZ, laminin-2 was intensively and predom-
inantly expressed in the matrix around lobules, including
basement membrane, whereas it was undetectable in the
TZ. The lobules in the NZ also expressed laminin-2, but
not as much as in the IZ (Figure 2C). In DCIS samples,
laminin-2 expression was weak or negative in both the
TZ and IZ (data not shown).
Figure 3. Epithelial-mesenchymal transition in the interface zone for
myofibroblast formation. A: Expression of TGF- transcript in IDC.
TGF- was highly upregulated in the TZ, and also moderately main-
tained in the IZ. B: Expression of MMP3, MT1-MMP, Twist, Snail, ZEB1,
and N-cadherin in each tissue zone of both DCIS and IDC. In the IZ of
IDC, MMP3 and MT1-MMP were significantly overexpressed compared
with the TZ and NZ. There was no difference between tissue zones in
DCIS, and even MT1-MMP was not expressed. Snail, ZEB1, and N-
cadherin were overexpressed in the IZ of IDC relative to the TZ and NZ,
whereas Twist was overexpressed only in the TZ of both DCIS and IDC.
C:miR 200c down-regulation as an EMT phenotype. miR200c was down-
regulated in the IZ coupled with the upregulation of ZEB1. Asterisk
denotes more than twofold increased expression and P  0.05 in the IZ.
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membranous pattern around vessels and within the tumor
burden. However, it showed intratumoral heterogeneity,
according to spatial area. Within the tumor nests, a pe-
ripheral-nested pattern was dominant, whether continu-
ous or not. Integrin 4 was remarkably accentuated
along the invading front of the tumor nests. DCIS was
predominantly negative except in the front margin (arrow-
marked) of the budding nest (Figure 2D).
Transition of Epithelial Cells to Myofibroblasts
via EMT in the IZ
The dense fibrotic zone, a distinct characteristic of the IZ of
IDC, allowed us to examine the expression of TGF-,
MMP3, MT1-MMP, and EMT-related factors. The TGF-
mRNA transcript was highly expressed in the TZ and mod-
erately maintained in the IZ where it was higher than in the
NZ (Figure 3A). MMP3 and MT1-MMP were specifically
overexpressed in the IZ of IDC tissue (Figure 3B). Of EMT
inducers, Twist, which is known as a tumor-specific marker
and master regulator of EMT, was expressed merely in the
TZ of both IDC and DCIS. On the other hand, Snail and
ZEB1 were particularly overexpressed in the IZ of IDC (Fig-
ure 3B). The gain of N-cadherin expression was observed
as an EMT phenotype (Figure 3B). The down-regulation of
miR200c, which was coupled with an upregulation of ZEB1
in the level of mRNA, another EMT phenotype, was also
detected in the IZ of IDC (Figure 3C).
Specialized Function of Fibroblasts Derived from
the IZ in Tumor Invasion
To examine whether fibroblasts derived from the TZ, IZ, and
NZ have distinct properties, we compared the molecules
previously confirmed in tissues  laminin-2, integrin 4,
MMP3, MT1-MMP, Snail, and ZEB1  in all three fibroblast
types. Laminin-2, Snail, and MT1-MMP were overex-
pressed only in interface zone-fibroblast (InF) cells, the
myofibroblasts derived from the IZ of IDC. Integrin 4 was
not expressed in any of the three fibroblast types (Figure
4A), and there was no significant difference in other factors
among the tested fibroblasts (data not shown). To under-
stand how the invasiveness of tumor cells affect the behav-
ior of fibroblasts, we co-cultured each fibroblast type with
less-invasive (MCF7) or high-invasive (MDA-MB-231)
breast cancer cell lines, and then compared the same
factors examined previously. MDA-MB-231, but not
MCF7, induced laminin-2 and integrin 4 expression in
all fibroblasts (Figure 4B).
Discussion
There have been many studies aimed at understanding
tumorigenesis and various trials to develop cancer treat-
ments to inhibit tumor formation. Unfortunately, because
the causes of tumor formation are diverse and multiple,
such studies have achieved limited success and have
not been widely applied to cancer therapies. To over-
come the limitations of previous studies, scientists haverecently begun to turn their attention to the TME, as well
as the tumor itself. Cross talk between tumor cells and the
TME is now recognized as critical for tumor progression,
which is closely associated with the malignancy of can-
cer.21 As mentioned previously, the wide variety of
causes of tumorigenesis is hampering the advancement
of cancer research and treatments. For this reason, the
common characteristic shared by malignant tumors may
be the best target for cancer treatment. Invasion is the
early and primary phase of tumor progression in almost
all malignant tumors. Thus, the relationship between the
tumor invasiveness and alterations in TME should be
studied. To understand this relationship, we first intro-
duced the novel concept of IZ, the tissue area showing
dense fibrosis, which we defined as a 5-mm-wide belt
surrounding the tumor burden and adjoining normal tis-
sue. A 5-mm-surgical margin is widely accepted for mar-
gin controlled surgery.3 In our study, the IZ was hypoth-
esized to be the actual tissue site of TME where tumor
invasion-promoting alterations actively occur, and we
compared the IZ with the TZ and NZ of both DCIS and
IDC tissues.
Although TME has been studied in various contexts,
such as angiogenesis, and the roles of fibroblasts and
adipocytes in tumor progression, no studies have defined
the extent of TME in tissue that directly affects tumor
behavior. This may be because TME is defined as the
entire group of stromal cells activated by a tumor or tumor
progression-attending stroma. Thus, the definition of TME
seems rather abstract and difficult to attain. In our study,
we considered the dense fibrotic zone, or the IZ, around
the tumor burden of IDC as the actual tissue site of TME,
because fibrosis is one of the common features of tumor
progression and contributes to TME alterations such as
basement membrane stiffening.5 Before studying the al-
terations in the IZ during tumor invasion, we had to con-
firm the distinctiveness of the IZ by comparing it with the
TZ and NZ in the context of gene expression. The ECM is
Figure 4. Tumor progression-specialized protein expression of the fibro-
blast derived from the interface zone. A: Comparison of fibroblasts derived
from the TZ, IZ, and NZ of IDC. Laminin-2, Snail, and MT1-MMP were
significantly overexpressed in fibroblasts from the IZ. B: Co-culture of fibro-
blasts with less (MCF-7) or high (MDA-MB-231) invasive breast cancer cell
line. High invasive breast cancer could induce laminin-2 and integrin 4 in
all fibroblasts, regardless of their origins.a major component of the TME, and ECM alterations
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IDC showed ECM gene expression patterns that were
distinct from both the TZ and NZ, including the specific
upregulation of LAMA3, LAMC2, ITGA6, and ITGB4,
overexpression of the corresponding proteins, laminin-
332 and integrin 64, intensive expression of laminin-2
in the matrix around lobules, and a strong membranous
pattern of integrin 4 around vessels. The entire gene
expression pattern of the IZ was also distinct from those
of the TZ and NZ, but was relatively similar to that of the
TZ. Overexpression of laminin-332 in the IZ of IDC was
rather surprising because laminin-332 expression de-
creases as breast cancer progresses.14,15 The functions
of laminin-332 in tumor progression are to lead tumor
migration and to maintain tumor survival during migration
by binding its receptors, integrin 64 or 31, on tumor
cells.23–25 Therefore, increased expression of laminin-
332 in the IZ may be the product of the proximate para-
crine intercellular interaction between invasive tumor
cells in the TZ and the myofibroblasts (InF) in the IZ to
prepare a suitable microenvironment for tumor invasion.
Laminin-332-rich tumor microenvironment in the IZ may
be able to continuously stimulate integrin-related signal-
ing pathways for migration and survival of the invading
Figure 5. Interface zone alterations that may occur in the early stages of tu
processes: (1) tumor cells in the TZ initially interact with CAF, and (2) some o
by tumor cells in the TZ begins to spread out to the IZ. (4) TGF- leads to
and ZEB1 upregulation in epithelial cells in the IZ through Rac1b. (6) The ep
specifically InF. (8) InF myofibroblasts continue increasing in number and fi
expressing MT1-MMP, which can induce the EMT of epithelial cells together with MM
and (11) activates other soluble MMPs for ECM remodeling by MT1-MMP expressiotumor cells. This may be supported by laminin-2 over-
expression in InF myofibroblasts, and this overexpression
may be a key player in the formation of laminin-332-rich
tumor microenvironment in the IZ for tumor migration and
survival. Both cancer-associated fibroblasts (CAF) and
normal breast fibroblasts expressed significantly less
laminin-2. Interestingly, both CAF and normal breast
fibroblasts could express laminin-2 after interacting di-
rectly with the highly invasive tumor cells, MDA-MB-231.
The induction of laminin-332 expression in fibroblasts
may be closely associated with tumor invasiveness. In-
creased expression of integrin 64 in the IZ of IDC can
also be evidence of TME alteration for tumor invasion.
Integrin 64 expression may be helpful or necessary for
stromal cell survival during ECM remodeling. Due to the
loss of connections during ECM remodeling, stromal cells
should die from anoikis. However, some stromal cells,
such as fibroblasts and adipocytes, should be protected
from anoikis to assist tumor progression. In this sense,
integrin 64 expression might support TME alterations
in the IZ for tumor progression. Integrin 4 expression
was not observed in all fibroblast types. However, inte-
grin 4 was expressed in all fibroblast types after direct
interaction with invasive tumor cells. It may be that some
asion. Peritumoral dense fibrotic zone of IDC may be formed by following
an undergo EMT and become invasive. Simultaneously, (3) TGF- produced
roduction in some stromal cells in the IZ. (5) Secreted MMP3 induces Snail
cells begin to transdifferentiate via EMT, (7) they become myofibroblasts or
m dense fibrosis in the IZ. (9) InF can enhance myofibroblast formation bymor inv
f them c
MMP3 p
ithelial
nally forP3. In addition, (10) InF can secrete laminin-332 to guide tumor progression,
n.
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AJP January 2011, Vol. 178, No. 1alterations of TME, such as integrin 4, require direct
contact with tumor cells.
Fibroblasts are known to play a positive role in tumor
progression. Thus, fibrosis of the IZ of IDC could be the
phenotype of tumor progression-promoting alterations in
the actual site of TME. EMT, a novel source of fibroblast
formation that causes fibrosis, has been observed during
the formation of interstitial fibroblasts from organ epithe-
lium, oncogenesis, and fibrotic tissue repair following
injury  a process known as fibrogenesis.26–28 In the IZ
of IDC, not a counterpart of DCIS, the following EMT-like
events were observed: the upregulation of Snail and
ZEB1, the gain of N-cadherin, and the down-regulation of
miR200c coupled with the upregulation of ZEB1. More-
over, TGF- was primarily expressed in the TZ, but also
maintained at moderate levels in the IZ. TGF- can in-
duce the expression of MMP3 in stromal cells, leading to
Snail upregulation through reactive oxygen species
caused by Rac1b in nontumoral epithelial cells, and then
finally the transition of epithelial cells to myofibroblasts.6,7
TGF- can also induce MT1-MMP,29 which leads to sim-
ilar results as MMP3, such as fibrosis in mammary
glands8 and EMT in prostate cancer.9 Therefore, we sug-
gest that TGF- produced in the tumor cells paracrini-
cally expended to the IZ and triggered the transition of
epithelial cells into myofibroblasts via EMT process in-
duced by MMP3 and MT1-MMP. This may be supported
by both MT1-MMP overexpression and Snail upregulation
in InF. Although MMP3 expression was not observed in
InF, it may play a more important function for myofibro-
blast formation in the IZ than MT1-MMP. In the initial
stage of myofibroblast formation, MMP3 may first trigger
the EMT of epithelial cells in the IZ, and then transdiffer-
entiated myofibroblasts could express MT1-MMP, which
may enhance the transition of epithelial cells into myofi-
broblasts by helping MMP3. The co-presence of laminin-
332 with TGF- in the IZ may also support complete EMT,
leading to myofibroblast formation.18 In previous studies,
the transition of tubular epithelial cells to myofibro-
blasts27,30 and the susceptibility of tubular epithelial cells
to EMT31 were reported. Therefore, the origin of InF may
be the epithelial cells from ductolobular units in the IZ
based on both intensive laminin-2 expression in the
matrix around lobules and laminin-2 overexpression of
InF. Taken together, we propose that InF may be respon-
sible for tumor invasion based on laminin-332 and MT1-
MMP overexpression. Laminin-332 is now widely recog-
nized to induce the motility of cancer cells with
integrins,25 and is associated with breast cancer metas-
tasis.32 In addition, MT1-MMP derived from fibroblasts
promotes tumor progression.33
Based on our results, we summarize the events in the IZ
of IDC leading to the formation of dense fibrosis during
tumor invasion as the following: (1) tumor cells in the TZ
initially interact with CAF and some in the TZ undergo EMT;
(2) at the same time, TGF- produced by tumor cells in the
TZ begins to spread out to adjacent tissue areas, the IZ; (4)
TGF- leads to MMP3 production in some stromal cells in
the IZ; (5) secreted MMP3 induces Snail and ZEB1 upregu-
lation in epithelial cells in the IZ through Rac1b; (6) the
epithelial cells begin to transdifferentiate via EMT and be-come myofibroblasts or InF; (7) InF myofibroblasts continue
to increase in number and finally form dense fibrosis in the
IZ; (8) InF can enhancemyofibroblast formation by express-
ing MT1-MMP, which can enhance the EMT of epithelial
cells together with MMP3, secrete laminin-332 to guide tu-
mor progression, and activate other soluble MMPs for ECM
remodeling by MT1-MMP (Figure 5).
The findings in our study raise some questions as
follows:
i) Is the InF cell population truly distinct from CAF?
ii) If so, how valuable is the InF population as a candi-
date for cancer therapy?
iii) What is the major source of InF cells in breast
cancer?
iv) Are there other factors required for InF formation
besides TGF-, MMP3, and MT1-MMP?
v) Are InF cells specialized for tumor invasion, as we
expect?
We will try to answer these questions in our future
studies and hope to better understand the relationship
between tumor invasiveness and TME alterations.
In conclusion, the IZ of IDC may be a distinct tissue
area based on its global gene expression pattern, spe-
cific molecular expression, and the dense fibrosis that
may be formed by the transition of epithelial cells to
myofibroblasts via EMT. In addition, a laminin-332 over-
expressing myofibroblast type (InF) in the IZ of IDC may
be critical for tumor invasion and survival. Therefore, the
IZ of IDC may be considered to be the actual tissue site
of TME where precedent alterations to enhance tumor
invasion actively occur. The IZ may prove to be a potent
target for cancer treatment, such as neoadjuvant therapy,
and a tissue area worthy of further study.
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